VEGFA and chronic kidney disease: In addition, the vascular endothelial growth factor (VEGF) signaling pathway, which was proven by previous studies to promote fibrosis in CKD (38), was lower in the PLR-H group than that in the HS group, suggesting that fibrotic signaling pathways were suppressed by high-dose PLR supplementation.